Table 2.

Mean years from screen detection to clinical detection by age at screen detection among men who would have been clinically diagnosed in their lifetimes (lead), mean years from onset to clinical detection by age at onset among men who would have been clinically diagnosed in their lifetimes (sojourn), and mean years from onset to metastasis by age at onset among men who would have developed metastatic disease in their lifetimes (local)

Age group	Lead	Sojourn	Local
50–54	7.8	18.5	21.7
55–59	8.0	16.4	19.4
60–64	7.7	14.2	17.0
65–69	7.0	12.0	14.5
70–74	6.2	9.7	11.8
75–79	5.4	7.4	9.0
80–84	3.2	5.2	6.2
Age-adjusted mean	7.0	13.5	16.1
Age-adjusted 95% CI	6.7–7.2	13.2–13.7	15.9–16.2